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Insights into specificity of cleavage and mechanism of cell entry
from the crystal structure of the highly specific Aspergillus
ribotoxin, restrictocin
Xiaojing Yang† and Keith Moffat*
Background: Restrictocin, a highly specific ribotoxin made by the fungus
Aspergillus restrictus, cleaves a single phosphodiester bond in the 28S RNA of
eukaryotic ribosomes, inhibiting protein synthesis. The sequence around this
cleavage site is a binding site for elongation factors, and is conserved in all
cytoplasmic ribosomes. The catalytic mechanism of restrictocin and the reasons
for its high substrate specificity are unknown. No structure has been determined
for any other member of the Aspergillus ribotoxin family.
Results: The crystal structure of restrictocin was determined at 2.1 Å resolution
by single isomorphous replacement and anomalous scattering techniques, and
refined to 1.7 Å resolution using synchrotron Laue data. The structural core of
the protein, in which a three-turn a helix is packed against a five-stranded
antiparallel b sheet, can be well aligned with that of ribonuclease T1. Large
positively charged peripheral loops near the active site construct a platform with
a concave surface for RNA binding.
Conclusions: Restrictocin appears to combine the catalytic components of T1
ribonucleases with the base recognition components of Sa ribonucleases.
Modeling studies using an NMR structure of an RNA substrate analog suggest
that the tertiary structure of the substrate RNA is important in protein–RNA
recognition, fitting closely into the concavity of the presumed binding site. We
speculate that the large 39-residue loop L3, which has similarities to loops found
in lectin sugar-binding domains, may be responsible for restrictocin’s ability to
cross cell membranes.
Introduction
Restrictocin is a basic cytotoxic protein of 149 amino acids
produced by the fungus Aspergillus restrictus. It belongs to
a specific class of ribosome-inactivating proteins (RIPs)
that can specifically cleave a single phosphodiester bond
in 28S rRNA of the eukaryotic large ribosomal subunit
and inhibit protein synthesis [1]. Other members of this
class of proteins are mitogillin from another strain of
A. restrictus, a-sarcin from Aspergillus giganteus and aspf1
from Aspergillus fumigatus [2,3]. They are often referred to
as the ‘Aspergillus ribotoxins’. Restrictocin differs in only
one residue from mitogillin and shares 86% sequence
identity with a-sarcin [4].
The restrictocin cleavage site in 28S rRNA is located on
the 3′ side of a guanosine residue in the sequence
AGUACGAG|AGGAAG [5]. This 14-nucleotide purine-
rich sequence, called the ‘a-sarcin domain’, is universally
conserved in cytoplasmic large subunit rRNAs [5]. The a-
sarcin domain is suggested to be a very important site in
protein synthesis. This domain is a major target for many
other ribotoxins, such as ricin, abrin, modeccin and tri-
chosanthin (from higher plants), shiga toxin (from Shigella
dysenteriae), verotoxins 1 and 2 (from Escherichia coli) and
tricholin (from Trichoderma viride). Despite their quite dif-
ferent enzymatic activities these toxins all target the same
domain [6-8]. Direct evidence for the further importance
of this domain comes from footprinting experiments, in
which elongation factors EF-1 and EF-2 ( EF-Tu and
EF-G in prokaryotes) were found to bind the same a-
sarcin domain of ribosomes [9,10]. Inhibition of protein
synthesis by the Aspergillus ribotoxins involves both pre-
vention of EF-1-dependent binding of aminoacyl tRNA
and GTP-dependent binding of EF-2 to their ribosomal
sites [11,12].
The most distinctive feature of the Aspergillus ribotoxins as
ribonucleases is their exceptionally high specificity for a
single phosphodiester bond within eukaryotic large subunit
rRNAs. Endo and Wool [13] showed that the cleavage site
of a-sarcin is located 393 nucleotides from the 3′ end of the
28S rRNA and generates 3′ phosphate and 5′ hydroxyl
products. Compared to other ribonucleases, restrictocin
shares 24% sequence identity with RNase T1 (T1) and
34% with RNase U2 (U2) [14]. Many of the conserved
residues are concentrated near the catalytic site of T1 and
U2, suggesting that a similar enzymatic mechanism holds
for the Aspergillus ribotoxins.
Address:  Department of Biochemistry and
Molecular Biology, The University of Chicago, 920
East 58th Street, Chicago, Illinois 60637, USA.
†Present address:  Department of Biochemistry,
Molecular Biology and Cell Biology, Northwestern
University, 2153 Sheridan Road, Evanston, Illinois
60208, USA.
*Corresponding author.
E-mail:  moffat@cars.uchicago.edu
Key words: cell-entry activity, Laue diffraction,
protein–RNA specific recognition, ribotoxins,
SIRAS
Received:  12 April 1996
Revisions requested:  25 April 1996
Revisions received:  31 May 1996
Accepted:  31 May 1996
Structure 15 July 1996, 4:837–852
© Current Biology Ltd ISSN 0969-2126
Research Article 837
Extensive studies on substrate specificity have been
carried out using a synthetic oligoribonucleotide (35-mer)
that reproduces the conserved nucleotides, and presum-
ably the secondary structure, of the a-sarcin domain of
ribosomes [15]. To retain substrate specificity, a stem con-
taining a minimum of three base pairs [16] and a guanine
base, six bases 5′ to the cleavage site, were found to be
essential [17]. In contrast, the bases around the cleavage
site can be altered without greatly affecting the substrate
specificity. These results strongly suggest that the tertiary
structure of the a-sarcin domain stem and loop, rather
than a simple conserved sequence, plays a critical role in
specific protein–RNA recognition.
How the Aspergillus ribotoxins get into cells to exhibit
their toxicity is not yet known. Toxins, like diphtheria
toxin, enterotoxin and ricin, either have distinctive
domains for receptor binding and translocation or employ
a second polypeptide chain to facilitate the translocation
of the catalytic subunit across the cell membrane [18-20].
In contrast, restrictocin, mitogillin and a-sarcin are small
basic proteins consisting of a single polypeptide chain.
a-Sarcin has substantially limited activity against intact
cells, although it is an effective inhibitor of in vivo protein
synthesis: in virus-infected cells [21,22]; in many tumor
cell lines [23], and in cells whose membrane permeability
has been modified by treatment with phospholipase C or
external ATP [24]. No cell surface receptors have so far
been identified which might be involved in the transloca-
tion of the ribotoxins. Studies on a-sarcin, using model
membrane systems, suggest that interactions between a-
sarcin and acidic phospholipids in membranes play an
important role in the cell-entry activity of the Aspergillus
ribotoxins [23,25-27].
It has recently been suggested that restrictocin is an insect
antagonist as it protects A. restrictus conidiophores from
insects that feed on fungi [28]. Restrictocin has also been
implicated in the pathogenesis of human aspergillosis, a
condition caused by A. fumigatus [29]. Aspf1, a protein dif-
fering in only two amino acid residues from restrictocin, was
shown to be the major antigen in the urine of patients with
invasive pulmonary aspergillosis. The expression of both
aspf1 protein and its mRNA in A. fumigatus and A. restrictus
(but not in other species of Aspergillus) [30] suggested that
aspf1 is a potential virulence factor for A. fumigatus-related
diseases. These diseases account for 80% of cases of human
aspergillosis.
We have determined the crystal structure of restrictocin at
2.1 Å resolution by single isomorphous replacement and
anomalous scattering techniques (SIRAS). The structure
was refined to 1.7 Å resolution using synchrotron Laue data.
This restrictocin structure is the first crystal structure deter-
mined for a member of the Aspergillus ribotoxin family.
With this crystal structure, we aim to understand the
catalytic mechanism, substrate specificity and cell-entry
activity of restrictocin.
Results
Quality of the model 
Two restrictocin molecules in the asymmetric unit were
independently built from the solvent-flattened, figure of
merit weighted Fo map, calculated from SIRAS phases at
2.1 Å resolution. This map was readily interpreted,
Figure 1a shows a typical region of the experimental
solvent-flattened SIRAS map. The model was refined using
cycles of iterative manual rebuilding and automatic refine-
ment with X-PLOR protocols [31] against both the mono-
chromatic FAST data at 2.1 Å resolution and the
synchrotron Laue data at 1.7 Å resolution. For the two mol-
ecules in one asymmetric unit, the final model consists of
285 amino acid residues, three phosphate groups and 204
water molecules. The crystallographic R factor is 17.7%
using synchrotron Laue data with F/sF >= 2 in the 8.0–1.7
Å resolution range with a free R factor of 23.7%. Figure 1b
shows the same region as in Figure 1a in the final 2Fo–Fc
map calculated with the refined phases at 1.7 Å resolution
using synchrotron Laue data. This map is of excellent
quality; holes can be seen in many aromatic side chains and
even in some proline residues at the 1s contour level. Most
water molecules are ordered and can be found in both mol-
ecules of restrictocin. The electron density for all carbonyl
oxygen atoms is very well defined so that cis-prolines
(Pro48, Pro112 and Pro126) can be easily assigned. The real
space correlation coefficients for most residues are greater
than 0.95, indicating a very good fit between the model and
the 2Fo–Fc map. No residues, other than glycines and pro-
lines, are found beyond the allowed regions in a Ramachan-
dran plot. The average error of the atomic coordinates is
about 0.18 Å as estimated by a Luzzati plot. The average
temperature factors for the main-chain and side-chain atoms
are 19.9 Å2 and 20.8 Å2, respectively. Six residues located
within a loop region are not visible in either molecule in the
asymmetric unit. This is presumably because these residues
are highly exposed to solvent and adopt numerous spatially
distinct conformations. The overall root mean square (rms)
deviation between the main-chain atoms of two monomers
in the asymmetric unit is 0.52 Å, indicating that they have
almost identical main-chain conformations.
Overall features 
Restrictocin is an a+b structure with approximate molecu-
lar dimensions 35 × 27 × 26 Å (Fig. 2a). A stereoview of the
Ca trace of restrictocin is shown in Figure 2c. The struc-
tural core consists of a five-stranded antiparallel b sheet
(strands B3, B4, B5, B6 and B7) stabilized by a three-turn
a helix (H1) in a perpendicular position. The curved
b strands are highly twisted in a right-handed manner and
form a shallow cleft. The twist is stabilized by a cluster 
of hydrophobic residues (Phe51, Ile68, Phe70, Ile122,
Val134, Leu144 and Leu146) that are tightly packed in
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the narrow end of the cleft. At the open end of the cleft,
the putative catalytic residues (His49, Glu95, Arg120 and
His136) are found. These residues all point towards an
inorganic phosphate group derived from the crystallization
buffer (Fig. 2b). 
Another long, two-stranded antiparallel b sheet (strands B1
and B2) is located at the N terminus of the structure and
immediately before the three-turn helix (H1). The six
residues which were not visible in the electron-density map
are located in the turn of loop L1 between strands B1 and
B2. Interestingly, the first two residues of helix H1, Ser25
and Gln26, also form part of strand B2; Ala1 O in strand B1
forms hydrogen bonds with Gln26 N and is involved in the
N-capping of helix H1. In addition, the N-terminal strand
B1 and the C-terminal strand B7 are linked by a disulfide
bond (Cys5–Cys147), which stabilizes the termini. A very
distinctive feature of restrictocin is the presence of large
connecting loops between b strands. Loops L2 and L4
interact with each other at the entrance to the catalytic
center (Fig. 2a). A 40-residue, glycine rich loop (L3)
between strands B3 and B4 forms an independent struc-
tural domain. This domain is linked to the structural core
by a disulfide bond (Cys75–Cys131) and by the hydropho-
bic residue cluster at the closed end of the cleft (Fig. 2b).
Structural alignments with other ribonucleases
As a ribonuclease, restrictocin was suggested to share a
similar enzymatic mechanism with T1 and U2 [14]. While
T1 and U2 specifically cleave at guanine bases, restrictocin
only cleaves a single phosphodiester bond in 28S rRNA in
the large ribosomal subunit and is specific for purines in
naked RNAs [13]. The antiparallel b sheet and an adjacent
long a helix which form the structural core of restrictocin
also represent a common structure motif found in other
ribonucleases including T1, RNase Ms (Ms), RNase Sa
(Sa), and barnase [32]. In restrictocin the major b sheet and
helix H1 are held together by a hydrophobic core formed
by Ala29 and Ala36 (from helix H1) and Phe96, Phe107,
Val121, Phe130 and Ile133 (from b strands). With a least
squares procedure (LSQKAB in the CCP4 package) we
have aligned the restrictocin structure against those of
ribonucleases T1, Ms, F1, Sa and barnase [33–37]. The rms
deviations between equivalent elements (limited by a 2.0 Å
cut-off) are listed in Tables 1,2. Sixty-two residues are
equivalent between restrictocin and T1, Ms and F1. The
substantial structural overlaps are observed in the regions of
both termini, helix H1, the major b sheet and in loops L2
and L5 (Fig. 3a). In addition, the disulfide bond that links
the N and C termini is conserved. Despite these extensive
similarities, structural differences between restrictocin and
T1 are prominent. The N-terminal antiparallel b strands
(B1 and B2) and the linking loop (L1) in restrictocin are,  in
total, 18 residues longer than the corresponding elements of
T1. Helix H1 in restrictocin is one turn shorter than in T1
due to the presence of a proline residue at the C terminus
of the helix sequence. However, the most striking differ-
ences between restrictocin and T1 are found in the periph-
eral loops. Loops L3 and L4 in restrictocin are significantly
larger than those in T1 and, despite their similar size, loops
L2 and L6 adopt different conformations from those in T1.
In contrast, only 18 residues can be reasonably well aligned
between restrictocin and Sa, barnase and RNase St (Table
2). Most of the conserved residues are located in the major
b sheet and very close to the catalytic center. Neither Sa or
barnase has the N-terminal antiparallel b sheet. Instead,
the N-terminal residues in Sa form an additional b strand
within the major antiparallel b sheet. In barnase there are
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Figure 1
Quality of the electron-density maps. (a) One typical region of the
experimental fom*Fo SIRAS map at 2.1 Å resolution. The map is
contoured at 1σ level. The tetrahedron at the upper right of the figure
represents a phosphate group and stars represent water molecules.
(b) The same region in the 2Fo–Fc map at 1.7 Å resolution
contoured at 1σ level. Both maps are displayed by Xfit in the
program XtalView [61].
three consecutive a helices at the N terminus, one of
which is in a position comparable to helix H1 in restric-
tocin. The topologically comparable long helix in Sa is dis-
placed from helix H1 in restrictocin by about 20° (Fig. 3b).
The active site
In the crystal structure of restrictocin, the putative cat-
alytic residues, His49, Glu58, Arg120 and His136, come
from different b strands in the major b sheet and line up
across this sheet (Fig. 2b). The side chains of these
residues cluster together at the open end of the cleft and
point towards a tetrahedral-shaped electron density. This
density was interpreted as an inorganic phosphate group
derived from the crystallization buffer. His49 Nδ1 forms
a hydrogen bond with the carbonyl oxygen of the next
residue (Trp50 O); His49 Nε2 interacts with a phosphate
oxygen (PO4 O1). Trp47 OH is also hydrogen bonded to
PO4 O1, benefited by the conformation of cis-Pro48.
Glu95 Oε2 is associated with a water molecule, which
belongs to a water network supporting the active-site
geometry. Glu95 Oε2 interacts with another phosphate
oxygen (PO4 O2). Arg120 Nε, Arg120 NH1 and
His136 Nε2 are all hydrogen bonded to PO4 O3. In addi-
tion to interactions with the phosphate group, the side
chain of Arg120 also makes contacts with loop L4, in
which Arg120 NH1 and Arg120 NH2 form hydrogen
bonds with Ala119 O and Gly117 O in L4 (Fig. 4). Many
main-chain atoms (Ala119 O, Gly117 O, Trp50 O,
Gly142 N and Asn140 O) and some water molecules also
contribute to the stabilization of the active site.
When the structures of restrictocin and the complex of T1
with 2′-GMP are superimposed, the main-chain and side-
chain atoms of Trp47, His49, Glu95, Arg120 and His136 in
restrictocin can be spatially aligned with the catalytic
residues Trp38, His40, Glu58, Arg77 and His92 in T1
with an rms deviation smaller than 0.1 Å (Fig. 3c). In addi-
tion, the phosphorus atom of the inorganic phosphate
group in restrictocin is 0.96 Å and 1.21 Å from the phos-
phorus atoms directly observed in the complex structures
of T1 with 2′-GMP and 3′-GMP, respectively [33,34].
These structural data strongly support the identification of
the catalytic residues from sequence alignment. Strong
conservation in the structural cores and the catalytic
residues suggests that restrictocin and T1 share a common
catalytic mechanism of RNA hydrolysis, by which the
same 3′ phosphate and 5′ hydroxyl groups are produced. 
Although the catalytic residues in Sa (Glu54, Arg69 and
His85) can also be well aligned with Glu95, Arg120 and
His136 in restrictocin, Val35 in Sa lies in the place of
His49 in restrictocin (Fig. 3d). As His49 is proposed to
serve as the general base in the phosphoryl transfer reac-
tion [38], this discrepancy either argues against the pro-
posed role for His49 in catalysis or suggests a different
enzymatic mechanism for Sa.
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Figure 2
The structure of restrictocin. (a) Ribbon
diagram of the restrictocin crystal structure
(generated with the program MOLSCRIPT
[66]). Assignment of the secondary structure
elements and the residues they contain are as
follows: B1: 1–10; L1: 11–16; B2: 17–24;
H1: 25–35; L2: 36–48; B3: 49–52; L3:
53–91; H2: 73–77; B4: 92–98; L4: 99–117;
B5: 118–125; L5: 126–131; B6: 132–137;
L6: 138–142; B7: 143–147. (b) Ribbon
diagram of restrictocin showing a view of the
cleft. Helices are depicted in blue, the N-
terminal b sheet is in yellow and the main
b sheet of the core is in green. At the open
end of the cleft, the catalytic residues are
shown in gray with oxygen and nitrogen atoms
in standard colors. These residues point to a
phosphate group (the tetrahedron shown in
yellow and red).  The other end of the cleft is
blocked by a cluster of hydrophobic residues
(in gray). The disulfide bonds are in orange.
(Figure produced with the program SETOR
[67]). (c) Stereoview of a Ca trace of
restrictocin, every tenth amino acid residue is
numbered. The electron density corresponding
to six residues in loop L1 could not be
visualized in either molecule in the asymmetric
unit and these residues are consequently
missing in the atomic model. See the text.
The base recognition site
Residues in a ribonuclease which interact with the base 5′
to the cleaved phosphodiester bond are often denoted
‘base recognition residues’. Structural alignment of restric-
tocin with T1 and Sa structures complexed with 2′-GMP
or 3′-GMP [33,34,36], identified Phe51, Thr52, Asn53 and
Arg65 as the base recognition residues in restrictocin
(Fig. 3e). Phe51, Thr52 and Asn53 are located in a type
I′ reverse turn (Thr52-Asn53-Gly54-Tyr55) at the start of
loop domain L3 of restrictocin; they are in positions com-
parable to Tyr41, Asn43 and Asn44 (in T1) and Phe37,
Gln38 and Asn39 (in Sa). Arg65 of restrictocin comes from
a different region of loop L3 and occupies a similar posi-
tion to Tyr45 in T1 and Arg40 in Sa. As the guanosine-
binding site is unoccupied in the crystal structure of
restrictocin, Thr52 N, Thr52 Oγ1 and Asn53 O are hydro-
gen bonded to three water molecules, HOH738, HOH875
and HOH876. These four- or five-centered water mol-
ecules form a hydrogen-bonding network which supports
the geometry of the empty base recognition site in restric-
tocin (Fig. 3f). It is clear that the active site of restrictocin
can accommodate 2′-GMP or 3′-GMP molecules in the
conformations and locations observed in the T1 or Sa
complexes. N7 and O6 of the guanine base would be
located at hydrogen-bonding distance from Thr52 N and
Asn53 N, both of which are thought to be key interactions
in conferring specificity for the guanine base in T1. N7
and O6 in the guanine base are predicted to be in equiva-
lent positions to HOH738 and HOH875 in restrictocin. In
other words, when 2′-GMP or 3′-GMP bind restrictocin,
we predict that only a few hydrogen bonded water mol-
ecules will be displaced and that little conformational
change will occur in the protein. The base recognition
residues of restrictocin are identical to those of Sa yet dif-
ferent from those of T1. Phe51 and Arg65 in restrictocin,
and Phe37 and Arg40 in Sa are equivalent to Tyr42 and
Tyr45 in T1. Therefore the ‘sandwich’ effect from the
phenolic side chains of Tyr42 and Tyr45 proposed to
account for the guanine specificity of T1 [34] might be
replaced in restrictocin by stacking interactions of the
aromatic ring from Phe51 and the guanidinium group 
from Arg65. 
A very important difference between restrictocin and
other ribonucleases is that restrictocin lacks a residue cor-
responding to Glu46 in T1 or Glu41 in Sa. The branched
side chain of this residue forms double hydrogen bonds
with N1 and N2 of the guanine base and thereby discrimi-
nates guanine from adenine [34,36]. The lack of this
residue in restrictocin could explain the observation that
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Table 1
Equivalent structural elements between restrictocin and ribonucleases T1, Ms and F1.
Restrictocin RNase T1 (1rnt)* RNase Ms (1rds)* RNase F1(1fut)*
residues Residues rmsd† Residues rmsd† Residues rmsd†
(Å) (Å) (Å)
3–5 4–6 0.33 5–7 0.29 4–6 0.18
22–34 9–21 1.14 10–22 1.09 9–21 1.03
47–53 38–44 0.30 37–43 0.40 38–44 0.33
68–70 48–50 0.78 47–49 0.69 48–50 0.73
93–99 56–62 0.51 55–61 0.50 56–62 0.53
103–105 66–68 0.27 65–67 0.22 65–67 0.34
115–124 72–81 0.32 71–80 0.27 72–81 0.38
127–136 83–92 0.61 82–91 0.59 83–92 0.59
143–148 99–104 0.62 98–103 0.52 99–104 0.75
*Accession code of the coordinates in the Protein Data Bank. †rmsd is the root mean square deviation between the main-chain atoms (CA,CB, C,
N, O) of equivalent structural elements.
Table 2
Equivalent structural elements between restrictocin and ribonucleases Sa and barnase.
Restrictocin RNase Sa (1gmp)* Barnase (1bns)*
residues Residues rmsd† (Å) Residues rmsd† (Å)
49–53 35–39 0.92 54–58 0.26
93–98 52–57 0.38 71–76 0.44
119–123 68–72 0.47 86–90 0.31
133 81 0.02 98 0.10
136 85 0.47 102 0.51
*Accession code of the coordinates in the Protein Data Bank. †rmsd is the root mean square deviation between the main-chain atoms (CA,CB, C,
N, O) of equivalent structural elements.
restrictocin is only purine-specific towards naked RNAs,
rather than guanine-specific as for T1 and Sa [15]. 
The alignments of the catalytic residues and base recogni-
tion residues of restrictocin and other ribonucleases are
shown in Table 3. The alignments were derived from their
crystal structures, except for U2 [39] and RNase Bi, for
which atomic coordinates are not yet available. According to
Tables 1,2, ribonucleases with similar folds fall into two
major groups: a T1 group and an Sa group. Restrictocin
seems to combine the catalytic components of the T1 group
with the base recognition components of the Sa group,
which reveals the functional relationship between the
Aspergillus ribotoxins and other ribonucleases. Table 3 also
suggests that if these ribonucleases share a common chemi-
cal basis for catalysis, His49 might not be directly involved
in bond cleavage and Asn53 may play an important role in
purine specificity.
The connecting loops
Most of the distinctive structural differences between
restrictocin and ribonucleases lie in the peripheral loop
regions; differences in loops L3 and L4 are prominent.
Loop L3 (53–91) is the longest loop in restrictocin with
two large structural insertions compared to T1. These
insertions span residues 52–67 and 69–92 (Fig. 3a,5). The
39 residues in L3 form a structural domain which is absent
in other ribonucleases. There are two major interactions
between this loop domain and the structural core: a highly
solvent-accessible disulfide bond (between Cys75 in L3
and Cys131 in strand B6); and a hydrophobic interaction
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Figure 3
Structural alignment between restrictocin (in
gray) and ribonucleases T1 (in green), and Sa
(in gold). (a) The overall folds of restrictocin
and T1; (b) the overall folds of restrictocin
and Sa. (c) The catalytic residues from
restrictocin (shown in gray and labeled in plain
text) and T1 (shown in turquoise and labeled
in italic text). The tetrahedral phosphate group
(in red and yellow) is from restrictocin and the
2′-GMP is from T1. Red spheres represent
the water molecules in restrictocin. (d) The
catalytic residues from restrictocin and Sa
(shown in gold and labeled in italic text). The
3′-GMP is from Sa. (e) The base recognition
residues of restrictocin and T1, the 2′-GMP is
from T1. (f) The base recognition residues of
restrictocin and Sa. The 3′-GMP is from Sa.
(All six figures produced by the program
SETOR.)
between a cluster of residues from L3 (Phe51, Ile68 and
Phe70) and the major b sheet (Leu93, Ile122, Val134,
Leu144 and Leu146) (Fig. 2b). The secondary structure
elements in the L3 domain include a one-turn helix (H2)
and several b turns of various types, which fold into four
mini-loops. The flexibility of this loop is suggested by the
presence of seven glycine residues, but in the crystal
lattice L3 is stabilized by extensive intermolecular con-
tacts, which may determine the conformation of the loop.
A chain of four ordered water molecules in L3 fills up a
gap by interacting with lateral residues (Phe51, Asn53,
Ile68, Leu93, Arg77, Cys75 and Asp76). This water chain
is found in both molecules of restrictocin in the asymmet-
ric unit, and might help stabilize the loop conformation in
the crystal lattice. Three adjacent restrictocin molecules
make contacts with L3. At one intermolecular interface,
an additional inorganic phosphate group is found. This
phosphate group interacts with Arg77 and His91 (from L3)
and with the C-terminal residue His149, from the adjacent
molecule related by the local 21 symmetry. The spatial
arrangement of Arg77, His91, His149 and the phosphate
group in the interface is very similar to that observed in
the active site and corresponds to the positions of the cat-
alytic residues Arg120, His136, His49 and the phosphate
group (PO4). In addition, five lysine and two arginine
residues make L3 highly positively charged. Lys60,
Lys63, Lys80, Lys88 and Arg65 line up at a ridge that
faces towards the entrance to the restrictocin catalytic
center. This positioning would allow these residues to
move in and interact with the negatively charged phos-
phate backbone of substrate RNA by forming specific
and/or non-specific salt bridges. These interactions might
be important in positioning the RNA loop of the substrate
towards the active site of restrictocin. 
Loop L4 contains five proline residues (Pro97, Pro100,
Pro112, Pro116 and Pro118), two at each end, and one at the
turn of L4; Gly102 and Gly117 are close to the ends of L4.
Compared to T1, in restrictocin there is an eight-residue
insertion at the turn of L4 (Fig. 3a), in which four lysine
residues are found (Lys106, Lys110, Lys111 and Lys113).
This insertion also makes contact with loop L2 at the
entrance to the catalytic center. The strategic positioning of
the lysine-rich loop (L4) implies a role in substrate-binding
and specificity. In the crystal lattice, L4 is very exposed to
solvent and its mobility is indicated by significantly higher
B factors for the residues in the loop (109–113).
Loop L1 (10–17) links the two N-terminal b strands
(Fig. 2a). In the crystal lattice L1 is fully exposed to
solvent and lacks electron density for residues 11–16. A
loop corresponding to L1 is totally absent in the T1 struc-
ture (Fig. 3a). In the sequence of L1, there is a proline
residue at the turn and two lysine and two asparagine
residues make L1 very hydrophilic. Loop L1 is distant
from the catalytic center of restrictocin, and no biochemical
data imply its involvement in either interactions with the
ribosomal surface or in the ability to enter cells.
Loop L2 (36–48) connects helix H1 and strand B3 in the
major b sheet, which is located at the entrance of the cat-
alytic site (Fig. 2a,b). The conformation of L2 is stabilized
by internal hydrogen bonds and intermolecular contacts.
Residues Lys42, Gly44 and Ser45 located at the turn of L2
make hydrogen bonds with Asp108 and Phe107 in loop L4.
In the crystal lattice this interloop interaction is reinforced
by Arg21 from the neighboring molecule, whose side-chain
atoms are hydrogen bonded with Lys42 O in L2 and
Asp108 Oδ1 and Asp108 Oδ2 in L4. The loop–loop inter-
actions between L2 and L4 might lead to the different
conformation of L2 in restrictocin from that in T1, despite
their identical lengths (Fig. 3a). 
Loop L5 is a tight turn of type VIa that links strands 
B5 and B6. Loop L6 between strands B6 and B7 is a
seven-residue loop in which Arg138, Gly139, Asn140 and
Gln141 form a type II′ turn. Three ordered water mol-
ecules (HOH749, HOH721 and HOH893) mediate hydro-
gen bonding in L6. Although both the length and
sequence of L6 are identical to those of T1, L6 in restric-
tocin is substantially displaced relative to the b strands
(Fig. 3a). In L6, Gln137 O and Gly39 N before the turn
are hydrogen bonded to Gln8 N, Gln8 O and Asn7 Nδ2
in strand B1; Asn140 O and Gly142 N after the turn inter-
act with the ordered water molecules in the active site
(HOH718, HOH723 and HOH722). Although the flexibility
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Figure 4
The hydrogen bonding network at the active site of restrictocin. The
main-chain and side-chain atoms involved in hydrogen bond formation
are labeled. Red balls represent water molecules and the phosphate
group is a tetrahedron shown in yellow and red. Turquoise dotted lines
represent hydrogen bonds.
of L6 would be facilitated by Gly139 and Gly142, Asn7
and Gln8 are likely to be responsible for the displace-
ment of the loop as these residues are absent in the T1
structure. The different loop conformations of L6 in the
restrictocin and T1 crystal structures may simply repre-
sent two selections of many possible conformations for a
flexible loop.
Surface properties
The molecular surface of restrictocin reveals a dome-
shaped protein with the active site located on the planar
side (Fig. 5a,b). Looking down on the active site , the cat-
alytic residues are located at one end of a shallow cleft,
which is extended by a large platform at the entrance
formed by loops L2 and L4 (Fig. 5a). The platform is about
20 Å wide, limited by loops L3 and L6 as the boundary. It
is plausible that the concave surface of the platform is the
surface in restrictocin that binds the substrate RNAs. The
surface of restrictocin is highly positively charged, which is
consistent with its very basic isoelectric point (pI~9.0)
established by isoelectric focusing gels (XY, unpublished
result). Most charges are uniformly distributed over the
surface except in two regions where positive charges are
concentrated. One region is the lysine-rich loop in L4
which looks like a knob at the edge of the platform (Fig.
5a,b). The other region is the positively charged ridge in
L3 (containing Lys60, Lys63, Lys80, Lys88 and Arg65)
that faces towards the platform. The locations of the two
clusters of positively charged residues also supports the
idea that the platform, formed by L2 and L4 at the
entrance of the catalytic site, is the extended binding site
of substrate RNA. 
Although restrictocin and T1 bear limited sequence and
structural identity, major differences in the peripheral loops
lead to very different molecular surfaces. As it lacks the
loop domain L3, T1 does not adopt a dome shape. There is
no platform at the entrance of the active site of T1 because
loop L4 is much shorter and L3 is in a very different con-
formation. The lysine-rich knob and the positively charged
ridge inserted in restrictocin are absent in T1 and make the
catalytic center of T1 more accessible. This comparison
suggests that the structural elements responsible for restric-
tocin substrate RNA binding are a landing platform (L2
and L4), a lysine-rich loop (L4) and a positively-charged
ridge in loop domain L3.
Crystal packing
There are two restrictocin monomers in one asymmetric
unit related by a non-crystallographic twofold screw axis.
In the crystal lattice one restrictocin monomer (model A)
contacts four adjacent molecules (model B) related by
crystallographic symmetry: B0 (x, y, z); B1 (1–x, y+1/2,
1–z); B2 (–x, y+1/2, 1–z); and B3 (x, y, z+1). Most interac-
tions at the interfaces are salt bridges between polar or
charged side chains. These are either direct interactions or
mediated by solvent molecules like waters or phosphate
groups. Two pairs of stacking interactions are formed
between an imidazole ring and an arginine guanidinium
group, His103A–Arg85B and His35A–Arg138B, in inter-
faces A0–B1 and A0–B2. Due to the non-crystallographic
symmetry, the four interfaces fall into two types. A0–B1
and A0–B2 are type I interfaces; A0–B0 and A0–B3 belong
to type II. Type I interfaces form a concave/convex fitting
between the active-site residues of one molecule and
residues from adjacent molecules (Lys28, Ser31 and His35
in H1; Asp101, Gly102, His103, Asp104, Lys113 and
Asn115 in L4). In the crystal lattice the active sites of both
molecules in the asymmetric unit are blocked to the point
where even a mononucleotide cannot readily diffuse in
(C Dealwis, unpublished results). The interfaces related
by non-crystallographic symmetry also differ in some
chemical details. One interesting example is that two
heavy-atom ions (Hg2+) bind His91A and His149B at one
of the type I interfaces but not the other, where instead a
phosphate group interacts with His91B and His149A. It is
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Table 3
Structural alignment of the catalytic and base recognition residues in restrictocin and other ribonucleases.
Ribonuclease Specificity Catalytic residues Base recognition residues* Available structures†
T1 G Tyr38 His40 Glu58 Arg77 His92 Tyr42–Asn43–Asn44–Tyr45–Glu46 2′GMP; 3′GMP; 2′AMP; free
Ms G>A>C>U His37 His39 Glu57 Arg76 His91 Tyr41–His42–Asp43–Tyr44–Glu45 3′GMP
F1 G Tyr38 His40 Glu58 Arg77 His92 Tyr42–Asn43–Asn44–Tyr45–Glu46 free; 2′GMP
U2 A>G Tyr38 His40 Glu61 Arg84 His101 n/a
Restrictocin G or A Tyr47 His49 Glu95 Arg120 His136 Phe51–Thr52–Asn53 Arg65 PO4
Sa G Arg65 Val35 Glu54 Arg69  His85 Phe37–Gln38–Asn39–Arg40–Glu41 3’GMP; 2’GMP
Barnase G Arg83 Asp54 Glu73 Arg87 His102 Phe56–Ser57–Asn58–Arg59–Glu60 free; d(GpC); barstar
St G Arg72 Thr42 Glu61 Arg76  His91 Phe44–Glu45–Asn4–Arg47–Glu48 SO4
Bi G Arg82 Asp53 Glu72 Arg86 His101 Phe55–Ser56–Asn57–Arg58–Glu59 n/a
*Base recognition residues refer here to those residues interacting
with the base in substrate RNA that is located 5′ to the
phosphodiester bond to be cleaved. †Several crystal structures are
available for many of the aligned ribonucleases both in free and
complexed forms, the types of complex are listed. Barstar is a small
protein inhibitor of barnase.
unlikely that either interface represents a biologically rele-
vant dimer association. A trace band of restrictocin dimer
was observed in SDS-PAGE gels run under reducing con-
ditions [23]. This observation might be due to random
reassociation of disulfide bonds between molecules; no
biochemical evidence suggests that the Aspergillus ribotox-
ins function as dimers in vivo. These intermolecular inter-
faces may simply reflect the way that the restrictocin
molecules pack in this P21 space group under our crystal-
lization conditions.
Discussion
Catalytic mechanism
Structural comparisons of restrictocin with other ribonu-
cleases reveal a T1-like structural core responsible for the
purine-specific ribonuclease activity of restrictocin. The
catalytic residues of restrictocin are identified as His49,
Glu95, Arg120 and His136. The high conservation of
sequence and tertiary structure, especially around the cat-
alytic center, strongly suggests that restrictocin shares its
catalytic mechanism with T1. Yang and Kenealy [40] con-
structed three point mutants of restrictocin, Glu95→Gly,
Glu115→Gly/His136→Leu and His136→Leu to test this
hypothesis. Using an in vivo yeast system and an in vitro
translation assay, they found that Glu95→Gly was partially
active while Glu115→Gly/His136→Leu mutants lost their
toxicity towards the host cells. This result suggests the
direct involvement of His136 in restrictocin catalysis.
Based on studies of T1 [33–35], we propose a two-step
reaction mechanism for restrictocin catalysis involving a
phosphoryl transfer reaction and a hydrolysis reaction. In
the phosphoryl transfer reaction step, His49/Glu95 in
restrictocin serves as the general base to abstract a proton
from the 2′OH of ribose; His136 acts as the general acid to
protonate the O5′ atom of the leaving nucleotide (product
5′OH), resulting in formation of a 2′-3′ cyclic phosphate
intermediate. The phosphorus atom of inorganic phos-
phate in the restrictocin structure is almost equidistant
from the O2′ and O3′ atoms of 3′-GMP in the T1 struc-
ture, within the restrictocin/T1 structure alignment. This
phosphate might represent the position of the actual phos-
phorus atom in the 2′-3′ cyclic phosphate intermediate. In
the hydrolysis reaction, the roles of the catalytic residues
are reversed; His136 works as the general base to activate
a water molecule and His49/Glu95 protonates the O2′
atom. The activated water molecule then attacks the
phosphorus atom in the intermediate and forms the
second product 3′ phosphate. No water molecule has been
found in the restrictocin model that corresponds to the
proposed activated water. The role of Arg120 is less clear.
It may stabilize the phosphate group through electrostatic
interactions or support the active-site geometry for the
proper positioning of the catalytic residues by forming
extensive hydrogen bonds (Fig. 4). Although Tyr47 con-
tributes to the hydrogen-bonding network of the active
site, and structurally can be very well superimposed with
Tyr38 of T1, its role in catalysis is not known.
Identification of the general base and general acid in the
catalytic mechanism of T1 is not unambiguous. Heine-
mann and Saenger [33] proposed a mechanism in which
Glu58 and His92 act as general base and general acid
respectively. The mechanism was based on the crystal
structure of T1 complexed with 2′-GMP and on early spec-
troscopic and kinetic studies. This model was challenged
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Figure 5
Charge distribution on the surface of restrictocin. Positive charges
from lysine and arginine residues are in blue; negative charges from
aspartic acid and glutamic acid residues are in red. (a) The figure
shows a dome-shaped restrictocin surface with the active site located
at the planar side. (b) A charge distribution surface with a view looking
down at the active site. Two major clusters of positive charges are
revealed around the active site: a long ridge from loops L3 and L6; and
a knob in loop L4 that is rich in lysines. (Surfaces are generated and
displayed with the program GRASP [65].)
by Nishikawa et al. [41], who observed high residual activ-
ity in the T1 mutant Glu58→Ala. They proposed a differ-
ent mechanism in which two histidines (His40 and His92)
act as a base-acid couple, as in the case of bovine pancre-
atic ribonuclease A [42]. Evidence from a study of the pH
dependence of catalysis in a series of T1 mutants [43] sug-
gests that the Glu58/His92 pair represent the required
base-acid couple and that His40 electrostatically stabilizes
the 2′-3′ cyclic phosphate intermediate. Our structural
comparison of restrictocin with T1 and Sa supports the
Glu58/His92 base-acid couple hypothesis. As T1 and Sa
have very similar overall folds and active-site geometry and
both are purine-specific, it is very likely that they employ
the same catalytic mechanism. Alignment of Val35 (Sa)
with His40 (T1) and His49 (restrictocin) may simply indi-
cate a non-essential role of His49 in restrictocin catalysis. 
The base recognition site
Structural alignments of restrictocin with T1 and its various
complexes indicate that in the active site and base-recogni-
tion regions, the restrictocin structure mimics T1 struc-
tures complexed with 2′-GMP or 3′-GMP more closely
than those complexed with vanadate, 2′-AMP or the free
enzyme [35,44,45]. In the free T1 structure or in com-
plexes with vanadate or 2′-AMP, an internal hydrophobic
residue, Val78, is found in two conformations; when the
guanine-recognition site is occupied in T1 complexes with
2′-GMP, 3′-GMP, 2′5′-GpG and 3′5′-pGp this residue is
well-ordered. In restrictocin, the active site is bound only
by a phosphate group from the crystallization buffer and
the counterpart residue, Val121, shows very well-defined,
ordered density. For the base-recognition residues (Fig.
3d), in contrast to Asn43N in the free T1 structure, which
points away from Guanine O6, Thr52N in restrictocin
points towards Guanine O6 in the alignment as does Asn43
N in the T1–2′-GMP or T1–3′-GMP complex structures.
This suggests that the subtle structural changes in T1
upon GMP binding, such as the 140° flip of the Asn43-
Asn44 peptide plane in T1 [35], might be initiated by
binding of the phosphate group at the catalytic site. This
binding then propagates to the base-recognition region,
and helps reinforce the interactions between restrictocin
and bases in the substrate RNA. Whether similar confor-
mational changes would happen in the base-recognition
site of restrictocin upon substrate binding will not be
known until the crystal structures of free restrictocin and
restrictocin–RNA complexes are solved. 
Docking experiments and substrate specificity
One of the most intriguing features of restrictocin is its
high substrate-specificity. Based on this restrictocin crystal
structure and the NMR structure of a 29-mer substrate
RNA analog, denoted E73 [46], we have built a preliminary
docking model. The model aims to identify the structural
elements responsible for substrate-specificity and specific
interactions between protein and substrate RNA. 
The conformation of E73 reveals a compact structure with
several purine–purine base pairs, a GAGA tetraloop and a
bulged guanosine adjacent to a reverse Hoogsteen AU
pair (Fig. 6a). Based on this E73 structure, a large number
of 35-mer variants were made in order to define the criti-
cal elements for specific recognition by a-sarcin of the
substrate [17]. In order to retain substrate specificity,
several features are required: G18 in the 35-mer (G16 in
E73) at the cleavage site is preferred but can be replaced
by any other base; G12 (corresponding to the bulged G10
in the E73 NMR structure) cannot be deleted or mutated;
a stem with a minimum of two base pairs is required to
tether the loop; and the GAGA tetraloop is preferred, but
it alone as a miniloop is not sufficient for specific recogni-
tion [16]. These results suggest an important role for the
tertiary structure of the substrate RNA in protein–RNA
specific recognition.
Surface curvature calculated by the program GRASP
reveals a concave surface near the catalytic site in the
dome-shaped restrictocin (Fig. 5a,b). As expected for an
RNA-binding site, this concave surface is populated with
basic residues, including a lysine-rich region at the turn of
loop L4 and basic residues lining up at the edge of loop
L3. With the help of the program GRASP, the following
constraints were applied in our docking experiment:
surface complementarity between the concave surface of
restrictocin and the loop head of E73; and the protruding
lysine-rich knob fitting into the major groove of the
helical stem of the RNA. Suggestively, the resultant
model of the complex locates the phosphorus atom at the
cleavage site (between G16 and A17) of E73 only 0.93 Å
away from the phosphate group in the restrictocin crystal
structure (Fig. 6a). In this docking model, the platform
formed by loops L2 and L4 provides the major interaction
interface with E73. Lys42 in L2 and Lys110-Lys111-
Pro112-Lys113 in L4 are in positions that could stabilize
interactions with the backbone of E73 by forming salt
bridges with negatively charged phosphates. The side
chains of Asp108 or Ser109 may form hydrogen bonds
with donor/acceptor atoms in bases of the substrate and
function as base discriminators. The positively charged
ridge, formed by Lys60, Lys63, Lys80, Lys88 and Arg65,
in loop L3 is close to the sugar-phosphate backbone of
G13–G16 in E73. The ridge in L3 might be extensively
involved in protein–RNA interactions. In addition, the
van der Waals surfaces of restrictocin and E73 fit each
other very well with a solvent-excluded surface area of
870 Å2 (Fig. 6b). 
Although the current docking model is still preliminary, it
provides interesting insights into the interactions between
restrictocin and E73. Firstly, G10 in E73 is known to be 
a base essential for the substrate-specificity [17]. In 
our model, G10 is close to the lysine-rich loop in L4
(Fig. 6a). Consistent with this interaction, a deletion in the
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lysine-rich loop (106–113) of restrictocin leads to loss of
substrate specificity (R Kao, J Davies, [abstract VII-5],
International Conference on the Structure and Function
of the Ribosome, Victoria, BC, Canada, May 1995). The
specific recognition between G10 and the lysine-rich loop
might be one of the key interactions responsible for the
substrate specificity. Single mutants in the lysine-rich
region could further identify key residues and the types of
interaction involved. Secondly, the phosphate group at the
cleavage site of E73 (A17) is in a very good position to
interact directly with the catalytic residues of restrictocin
(Fig. 6a). Glück and Wool [17] showed that a two-base
insertion between the cleavage site and the bulged G10 of
E73 resulted in a two-base shift of the cleavage site; they
suggested the existence of a molecular ruler between the
active site and the specific recognition region, such as G10
in E73. Finally, by comparisons with other ribonuclease
structures, complexed with 2′- or 3′-GMPs, we identified a
base-recognition site in restrictocin (Fig. 3e,f). The base-
recognition site is empty in this docking model, probably
because both components of the model (restrictocin and
E73) are assumed to be rigid. In addition, the GAGA
(14–17) tetraloop in the E73 NMR structure is folded in a
closed conformation with A15, G16 and A17 stacking
together and base pairing between G14 and A17. It is pos-
sible that when restrictocin binds to E73, the GAGA
tetraloop will open up so that G16 could be properly posi-
tioned in the base-recognition site of restrictocin and
interact with the base-recognition residues, Phe51, Thr52
and Asn53. This conformational change is compatible with
the positioning of the GAGA tetraloop in the current
docking model. 
Loop domain L3 and cell-entry activity
As a ribotoxin, restrictocin has the ability to enter cells, a
property which related ribonucleases such as T1 lack.
However, unlike ricin for which the B chain facilitates
entry of the catalytic A chain into cells [47], restrictocin is
a single chain ribotoxin that apparently translocates across
the cell membrane without the involvement of other pro-
teins. Although the Aspergillus ribotoxins have shown very
limited cell-entry activity against intact cells in vitro, they
can enter virus-infected cells and many tumor cell lines.
When the Aspergillus ribotoxins were tested as antitumor
drugs, they were proved to be toxic [14], suggesting that
restrictocin can also get into normal cells and attack their
ribosomes. What structural elements in restrictocin might
be responsible for its cell-entry activity?
The structural feature in restrictocin which distinguishes
it most from T1 is the large 39-residue loop (L3) between
b strands B3 and B4 that forms an extra loop domain in
restrictocin. There are no secondary structure elements in
L3 except for an a helix with a single turn. A disulfide
bond in L3 splits the loop into two topological loops. The
loops stretch out in a direction perpendicular to the con-
necting strands, which looks like a ship anchor (Fig. 7a).
Before the crystal structure of restrictocin was known, it
was thought that this loop might be responsible for the
specific recognition of substrate RNAs (J Smith, personal
communication). However, neither the free restrictocin
structure nor the docking model for the restrictocin–RNA
complex indicates direct and essential involvement of
loop L3 in the specific recognition. From the structural
analysis of restrictocin, we speculate that the loop domain
Research Article Structure of restrictocin Yang and Moffat    847
Figure 6
A docking model derived from the restrictocin
crystal structure and the NMR structure of a
29-mer RNA substrate analog (E73). (a) The
figure shows the positioning of the bulged
guanosine residue (G10) and G16 (both in
gold) at the cleavage site of E73 (in gray) with
respect to the charge distribution of
restrictocin. (b) The surface complementarity
between restrictocin and E73 shown in a 90°
view from that of (a). Surfaces, where the
surface curvature calculated by GRASP is
positive, are shown in blue and red for
restrictocin and E73, respectively.
L3 might be related to the cell-entry ability of restrictocin.
Interestingly, similar large loop conformations are also
found in the sugar-binding domains of some lectin struc-
tures, such as ricin B chain [48,49], rat mannose-binding
protein (MBP) [50] and some plant lectins [51,52]. Ricin B
chain consists of six copies of a galactose-binding motif,
which contains 40 residues closed by two adjacent anti-
parallel b strands. It is believed that the ricin B chain can
bind reversibly to galactose residues presented by cell
surface glycopeptides and/or glycolipids and facilitates the
uptake of the whole molecule of ricin (A and B chains) by
endocytosis [48,49]. Significantly, this loop is topologically
similar to the loop domain L3 of restrictocin (Fig. 7b).
Other proteins are known to contain similar large loops:
the calcium-dependent lectin domain of a rat MBP, lectin-
like domain in CD69, E selectin, lectin-homology domain
in murine IgE receptor and P-selectin (CD62) (Fig. 7c).
Divalent ions such as Ca2+ and/or Mg2+ are ligated in these
loops, and involvement of the loops in sugar-recognition
has been implied by mutational studies [50,53–55]. As in
restrictocin, these loops form independent loop domains;
they often consist of four small loops lacking regular sec-
ondary structure elements and the loops are closed by an
adjacent antiparallel b strand. Plant lectins with similar
loops in sugar-binding domains include lentil lectin,
legume isolectins I and II, pea lectin and peanut lectin
[51,52] (Fig. 7d). These plant lectins share similar b sand-
wich tertiary folds. Divalent ions (Ca2+ and Mg2+) and car-
bohydrate bind large loops clustered at one side of the b
sandwich. Although these large loops are topologically
similar, similarity in their primary sequences is poor and
tertiary structural alignment of these loops does not seem
very satisfactory. This is not surprising, as loops involved in
cell surface recognition, such as those in heavy chain vari-
able regions of immunoglobin structures, may confer their
specificity by adopting different tertiary conformations. 
In order to understand the cell entry mechanism of a-
sarcin, Gavilanes and colleagues have studied the inter-
actions between a-sarcin and lipids using model membrane
systems and several tumor cell lines. They have shown that
a-sarcin interacts with phospholipid vesicles and promotes
their aggregation and fusion [25,26]. The secondary struc-
ture of a-sarcin seems to be modified upon interactions
with acid phospholipids or detergents like sodium dodecyl-
sulfate (SDS) [26]. a-Sarcin can penetrate the lipid bilayer
of tRNA-containing asolectin liposomes and degrade
entrapped tRNAs, or be itself degraded by encapsulated
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Figure 7
Comparison of loop domains (in red) in
restrictocin and other sugar-binding proteins.
The loop domains of four proteins are
compared: (a) restrictocin; (b) one domain of
ricin B chain; (c) rat mannose-binding protein
(MBP); and (d) lentil lectin, as an example of a
plant lectin. Disulfide bonds are shown in
yellow. The yellow spheres represent cation-
binding sites and the tetrahedron a
phosphate-binding site.
trypsin [27]. Extracellular a-sarcin can enter tumor cells
and inhibit protein synthesis in the absence of any other
agents affecting membrane permeability [23]. Kinetic
analysis of this inhibition revealed an a-sarcin-concentra-
tion dependent lag phase followed by a first order decrease
of the protein synthesis rate. These studies all suggest a
translocation mechanism that involves protein–lipid inter-
actions, which might also be rate-limiting in in vivo cyto-
toxic actions.
Loop L3 in restrictocin might recognize sugars in cell
surface glycolipids or glycopeptides and thereby promote
the endocytosis of restrictocin. Alternatively, the posi-
tively charged residues in L3 interact with negatively
charged phospholipids in cell membranes, as observed
with an in vitro model membrane system [25]; this inter-
action induces an aggregation and fusion of the membrane
that helps restrictocin molecules get into the cell.
Biological implications
Restrictocin is a highly specific ribotoxin that cleaves a
single phosphodiester bond in rRNA out of 7000 such
bonds in eukaryotic 28S ribosomes. The cleavage site is
located within a highly conserved purine-rich sequence,
which is also the binding site for elongation factors. Many
biochemical and mutational studies have been carried 
out on both ribotoxins and RNA substrate analogs.
However, the molecular basis for the catalytic mecha-
nism, substrate specificity and how the ribotoxins get into
cells are not understood. Here we report the crystal struc-
ture of restrictocin at 1.7 Å resolution, the first structure
determined of a member of the Aspergillus ribotoxin
family. Structural comparison with other ribonucleases
reveals an RNase T1-like structural core in restrictocin
that is responsible for its ribonuclease activity via an iden-
tical catalytic mechanism. A distinctive feature of the
restrictocin structure is large flexible loops which join sec-
ondary structure elements of the structural core. Two
loops at the entrance of the active site form a platform
that might specifically recognize substrate RNAs. A
lysine-rich segment in loop L4 and a positively charged
ridge in loop domain L3 are also implicated in the binding
of substrate RNAs. The loop domain L3 may also func-
tion as an anchor for the membrane translocation of
restrictocin. This crystal structure will guide biochemists
and molecular biologists in their studies of the Aspergillus
ribotoxins, in order to understand protein–RNA specific
interactions, develop therapeutic immunotoxins and
explore pathogenic mechanisms of Aspergillus related
human diseases.
Materials and methods
Crystallization
A combination of vapor diffusion and microdialysis techniques were
used to crystallize restrictocin [56]. The two-step equilibration greatly
slows down the growth rate of crystals and proved to be essential to
obtain large crystals of restrictocin. The final mother liquor consists of
60% ethanol, 10 mM sodium phosphate at neutral pH 6.8 and 10 mg
ml–1 restrictocin. Crystals form long rods in one week with a typical size
of 0.3 x 0.3 x 0.8 mm. These crystals can diffract up to 1.6 Å resolution
with a laboratory X-ray source and up to at least 1.4 Å on Laue images
collected at the NSLS X26C beamline [57]. Precession photos show
that restrictocin crystals are in P21 space group with cell dimensions
a = 50.24 Å, b = 82.16 Å, c = 38.04 Å and b = 100.5. This cell is
closely similar to that of mitogillin [56]. There are two molecules of
restrictocin per asymmetric unit with a solvent content of about 46%.
Data collection and SIRAS phasing
The HgCl2 derivative crystals were produced by soaking native crystals
in a solution containing 0.1 mM HgCl2, 10 mM sodium phosphate and
67% ethanol for about 36 h. Native and HgCl2 derivative data sets
used in primary phasing were collected on an in-house Enraf Nonius
FAST area detector. Reflections for each scan were indexed and inte-
grated by the programs MADNES and PROCOR. Individual scans
were then scaled and merged by monochromatic scaling algorithms in
the program LaueView, including isotropic scaling factor, isotropic tem-
perature factor, anisotropic scaling factor and anisotropic temperature
factors [58–60]. To complete an anomalous data set, two crystals of
the HgCl2 derivative were used. Both isomorphous and anomalous dif-
ference Patterson maps are of excellent quality; they are the key to our
successful structure determination by single isomorphous replacement
and anomalous scattering (SIRAS) techniques. Initial heavy-atom posi-
tions were refined by the program Xheavy in the XtalView suite [61].
SIRAS phases at 2.1 Å resolution were then calculated by PHASES,
followed by 16 cycles of solvent-flattening and yielded a final figure of
merit 0.884. Data collection and phasing statistics are shown in Tables
4 and 5. The initial atomic model was built using the program Xfit in the
XtalView suite against the figure of merit weighted Fo (fom*Fo) SIRAS
map at 2.1 Å resolution. 
The self-rotation function of the native data set of restrictocin, calcu-
lated by POLARRFN in the CCP4 program suite [62], reveals two
peaks at k =180°. One of the non-crystallographic twofold axes lies
along the a axis, which, in combination with the perpendicular crystallo-
graphic 21 b axis, generates the third non-crystallographic axis along c*.
The packing of restrictocin monomers in real space reveals translations
associated with each non-crystallographic twofold axis and suggests a
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Table 4
Data collection statistics.
Data set Native HgCl2 HgCl2
(isomorphous) (anomalous)
Number of crystals 2 2 2
Resolution (Å) 15.0–2.0 15.0–2.0 15.0–2.0
Number of unique 18 989 18 567 35 848
reflections
Mean redundancy 5.32 6.39 3.31
Completeness (%)
15.0–2.2 (Å) 99.3 99.2 96.0
2.2–2.1 (Å) 92.5 94.5 81.1
Rmerge* (%) 3.52 5.16 5.16
Rdifference† (%)
15.0–2.5 (Å) _ 19.1 7.9
*Rmerge = (Σhkl Σi|Ii–I|) / (Σhkl Σi (Ii)), where Ii is one measurement of a
unique reflection hkl and I is the mean of all the measurements for the
reflection hkl. †Rdifference = Σhkl ||F1|-k|F2|| / Σhkl |F1|, where k is a scale
factor. The summation is over all common reflections of two data sets.
For the isomorphous difference, F1 and F2 represent structure factors
from the native and derivative data sets. For the anomalous difference,
F1 and F2 are the structure factors for a Friedel pair (F+ and F–). 
pseudo-P212121 symmetry in restrictocin crystals. The two monomers
in the asymmetric unit were independently traced; molecular averaging
by Xfit was only applied in model building where ambiguity in chain
tracing occurred.
Laue data collection and structure refinement
The 1.7 Å resolution Laue data set was reduced from 62 Laue images
collected at the X26C beamline of the National Synchrotron Light
Source (NSLS) at Brookhaven National Laboratory. The exposure time
for the first 31 Laue images was 0.5 ms; for an additional 31 images a
10 ms exposure time was used to enhance high-resolution reflections.
The total exposure time was about 325 ms. Laue data reduction was
carried out by the program LaueView, including both singles and decon-
voluted multiples after wavelength normalization and harmonic deconvo-
lution [58,59] (Table 6). Detailed Laue data collection and reduction
stategies will be reported in a separate paper (XY, unpublished data).
The model was refined against both the FAST data at 2.0 Å resolution
and then Laue data at 1.7 Å resolution with protocols in the X-PLOR
package, alternating with manual model rebuilding against (2Fo–Fc) and
(Fo–Fc) maps by Xfit. This is the first time, to our knowledge, that a com-
plete set of high-resolution synchrotron Laue data was used in the con-
ventional refinement of a new structure. This example demonstrates the
potential of the Laue method for routine, high quality data collection at
synchrotron beamlines, in addition to its long recognized advantages in
data collection speed and in time-resolved crystallographic studies.
Structure analysis
The stereochemistry of the restrictocin model was checked with
PROCHECK [63]. A Ramachandran plot showed that 92% of the
residues in the two independent monomers lie in the most favored
region and none in disallowed regions. The real space correlation coeffi-
cients were examined as a function of residue number, as implemented
in the program O [64]. Tertiary structural alignments with other ribonu-
cleases were carried out using the programs LSQKAB, COMPAR in
the CCP4 suite of programs and Xfit in XtalView. The charge distribu-
tion surface and surface curvature of restrictocin were calculated and
displayed by the program GRASP [65].
Accession number
The atomic coordinates will be deposited in the Brookhaven Protein
Data Bank.
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